Support for traditional small molecule design
While BioLuminate has been developed with the design of bio-pharmaceuticals as its focus, we recognize that a computational scientist is frequently presented with a variety of projects, including those that involve small molecule design. For that reason, BioLuminate fully supports Schrödinger’s extensive suite of small molecule-centric tools including small molecule docking, pharmacophore analysis, and quantum mechanics. Any functionality available through Schrödinger’s traditional Maestro platform can be accessed, under license, in BioLuminate.
Built on Schrödinger’s industry-leading science
A core reason Schrödinger has been a leader in the field of scientific software is our concentration on not simply reproducing the literature but also moving the field forward with cutting edge work in methodology development and parameterization. BioLuminate is built on the core Schrödinger framework and has full access to Schrödinger development resources and infrastructure.
Extensive ongoing validation
We understand that it is one thing to present a method, and another to validate that the method is useful and to determine how best to use it. Schrödinger’s large research team - unparalleled among commercial software developers in our field - is working, and will continue to work, to validate and improve the methods within BioLuminate. In doing so, we ensure that the software continues to grow and improve.
A redesigned default interface
We have designed the BioLuminate interface to look and feel like PyMOL - the most widely used molecular visualization program in the world. The PyMOL-like interface is designed to encourage a common language between computational and experimental scientists, and to reduce the learning curve. While we expect this new interface to be popular among most users, the full set of BioLuminate tools can also be accessed through the standard Maestro interface.
Availability
BioLuminate is available in Schrödinger’s Suite 2012 software release. We encourage you to request a demo or evaluation of BioLuminate by contacting your Account Manager. Initial customer response has been positive and we are confident that we have developed the best and most comprehensive structure-based biologics design suite in the industry. In addition, we are continuing our product development efforts and look forward to receiving your feedback to guide future enhancements to BioLuminate.